PMC:7088323 / 14025-14384 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T79","span":{"begin":264,"end":272},"obj":"Disease"},{"id":"T80","span":{"begin":319,"end":334},"obj":"Disease"},{"id":"T81","span":{"begin":350,"end":358},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0006932"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T162","span":{"begin":62,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T163","span":{"begin":208,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T164","span":{"begin":208,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":208,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T42","span":{"begin":319,"end":334},"obj":"Phenotype"}],"attributes":[{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0100598"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T97","span":{"begin":0,"end":27},"obj":"Sentence"},{"id":"T98","span":{"begin":28,"end":189},"obj":"Sentence"},{"id":"T99","span":{"begin":190,"end":359},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"0_colil","denotations":[{"id":"32193638-18195376-54934","span":{"begin":175,"end":177},"obj":"18195376"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"TEST0","denotations":[{"id":"32193638-147-153-54934","span":{"begin":175,"end":177},"obj":"[\"18195376\"]"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"MyTest","denotations":[{"id":"32193638-18195376-29362787","span":{"begin":175,"end":177},"obj":"18195376"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"2_test","denotations":[{"id":"32193638-18195376-29362787","span":{"begin":175,"end":177},"obj":"18195376"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"269","span":{"begin":250,"end":258},"obj":"Species"},{"id":"270","span":{"begin":264,"end":272},"obj":"Disease"},{"id":"271","span":{"begin":319,"end":334},"obj":"Disease"},{"id":"272","span":{"begin":338,"end":346},"obj":"Disease"},{"id":"273","span":{"begin":350,"end":358},"obj":"Disease"}],"attributes":[{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"Tax:9606"},{"id":"A270","pred":"tao:has_database_id","subj":"270","obj":"MESH:C000657245"},{"id":"A271","pred":"tao:has_database_id","subj":"271","obj":"MESH:D011654"},{"id":"A272","pred":"tao:has_database_id","subj":"272","obj":"MESH:D005355"},{"id":"A273","pred":"tao:has_database_id","subj":"273","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Subpleural curvilinear line\nThis manifestation was defined as a thin curvilinear opacity with 1–3 mm thickness, lying less than 1 cm from and parallel to the pleural surface [26] (Fig. 4b). Wu et al [15] and Li et al [23] both reported around 20% of patients with COVID-19 demonstrated this sign, which might relate to pulmonary edema or fibrosis of COVID-19."}